Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Fukushima

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
World Journal of Gastroenterology|June 15, 2006
Bioinformatic approach for understanding the heterogeneity of cholangiocytesKoji Fukushima, Yoshiyuki Ueno
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 17, 2010
Treatment of Primary Biliary Cirrhosis: A new challenge?Koji Fukushima, Yoshiyuki Ueno, Tooru Shimosegawa
Microbiology Spectrum|February 16, 2022
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to BrincidofovirNozomu Hanaoka, Masatoshi Hazama, Koji Fukushima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Bioinformatic approach for cholangiocyte pathophysiologyYoshiyuki Ueno, Koji Fukushima, Yu Nakagome, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2006
Filopodia formation via a specific Eph family member and PI3K in immortalized cholangiocytesKoji Fukushima, Yoshiyuki Ueno, Jun Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 8, 2008
Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinomaYasunori Matsuda, Yoko Yamagiwa, Koji Fukushima, et al.
Hepatology International|August 13, 2015
Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirinMasahiko Nakayama, Hisanori Kobayashi, Koji Fukushima, et al.
Gynecologic Oncology|September 11, 2016
A comparison of overall survival with 40 and 50mg/m<sup>2</sup> pegylated liposomal doxorubicin treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world dataMasahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 14, 2009
Compensatory role of inducible annexin A2 for impaired biliary epithelial anion-exchange activity of inflammatory cholangiopathyOsamu Kido, Koji Fukushima, Yoshiyuki Ueno, et al.
The Tohoku Journal of Experimental Medicine|October 6, 2007
The high incidence of the emergence of entecavir-resistant mutants among patients infected with lamivudine-resistant hepatitis B virusFutoshi Nagasaki, Hirofumi Niitsuma, Yoshiyuki Ueno, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|June 15, 2006
Bioinformatic approach for understanding the heterogeneity of cholangiocytesKoji Fukushima, Yoshiyuki Ueno
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 17, 2010
Treatment of Primary Biliary Cirrhosis: A new challenge?Koji Fukushima, Yoshiyuki Ueno, Tooru Shimosegawa
Microbiology Spectrum|February 16, 2022
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to BrincidofovirNozomu Hanaoka, Masatoshi Hazama, Koji Fukushima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Bioinformatic approach for cholangiocyte pathophysiologyYoshiyuki Ueno, Koji Fukushima, Yu Nakagome, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2006
Filopodia formation via a specific Eph family member and PI3K in immortalized cholangiocytesKoji Fukushima, Yoshiyuki Ueno, Jun Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 8, 2008
Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinomaYasunori Matsuda, Yoko Yamagiwa, Koji Fukushima, et al.
Hepatology International|August 13, 2015
Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirinMasahiko Nakayama, Hisanori Kobayashi, Koji Fukushima, et al.
Gynecologic Oncology|September 11, 2016
A comparison of overall survival with 40 and 50mg/m<sup>2</sup> pegylated liposomal doxorubicin treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world dataMasahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 14, 2009
Compensatory role of inducible annexin A2 for impaired biliary epithelial anion-exchange activity of inflammatory cholangiopathyOsamu Kido, Koji Fukushima, Yoshiyuki Ueno, et al.
The Tohoku Journal of Experimental Medicine|October 6, 2007
The high incidence of the emergence of entecavir-resistant mutants among patients infected with lamivudine-resistant hepatitis B virusFutoshi Nagasaki, Hirofumi Niitsuma, Yoshiyuki Ueno, et al.
Pageof 6